Lidija Klampfer
Department of Oncology
Albert Einstein Cancer Center
Montefiore Medical Center
Bronx
USA
Name/email consistency: high
- The role of signal transducers and activators of transcription in colon cancer. Klampfer, L. Front. Biosci. (2008)
- Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21. Klampfer, L., Huang, J., Shirasawa, S., Sasazuki, T., Augenlicht, L. Cancer Res. (2007)
- STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation. Klampfer, L., Huang, J., Kaler, P., Sasazuki, T., Shirasawa, S., Augenlicht, L. Oncogene (2007)
- Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Klampfer, L. Curr. Cancer. Drug. Targets (2006)
- Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis. Klampfer, L., Swaby, L.A., Huang, J., Sasazuki, T., Shirasawa, S., Augenlicht, L. Oncogene (2005)
- Requirement of histone deacetylase activity for signaling by STAT1. Klampfer, L., Huang, J., Swaby, L.A., Augenlicht, L. J. Biol. Chem. (2004)
- Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression. Klampfer, L., Huang, J., Sasazuki, T., Shirasawa, S., Augenlicht, L. J. Biol. Chem. (2004)
- Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression. Klampfer, L., Huang, J., Corner, G., Mariadason, J., Arango, D., Sasazuki, T., Shirasawa, S., Augenlicht, L. J. Biol. Chem. (2003)